{"id":"W2005507799","doi":"10.3747/co.20.1226","title":"Overall Survival Should Be the Primary Endpoint in Clinical Trials for Advanced Non-Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical endpoint; Surrogate endpoint; Oncology; Pemetrexed; Internal medicine; Lung cancer; Clinical trial; Progression-free survival; Cancer; Crizotinib; Chemotherapy; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2486267,0.00142588,0.005512078,0.00125787,0.0012678,0.005436508,0.001352741,0.006044588,0.004716048],"category_scores_gemma":[0.3158103,0.0005571293,0.003489854,0.001843926,0.003050551,0.005583901,0.001857332,0.009332937,0.002001386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002587539,"about_ca_system_score_gemma":0.005592632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002994256,"about_ca_topic_score_gemma":0.000567799,"domain_scores_codex":[0.6834974,0.2657175,0.02915196,0.003879391,0.01676492,0.0009887599],"domain_scores_gemma":[0.6247397,0.2863268,0.04431369,0.01362719,0.02569856,0.00529406],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05123004,0.001035219,0.009453273,0.03967195,0.008574814,0.0002181749,0.0007782141,0.001624208,0.002751696,0.05267852,0.1515871,0.6803969],"study_design_scores_gemma":[0.03446557,0.03557226,0.03822226,0.03645817,0.00794382,0.0006727818,0.0006338568,0.005483123,0.004956424,0.09862537,0.7364831,0.0004832164],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.0177059,0.442052,0.07679804,0.2756375,0.1183709,0.01698458,0.003332176,0.000637648,0.04848123],"genre_scores_gemma":[0.3138771,0.126005,0.1556341,0.2257883,0.09836151,0.05896866,0.002826039,0.0008753132,0.01766399],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.7513734,"threshold_uncertainty_score":0.9265771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3022978229486874,"score_gpt":0.5550188770654189,"score_spread":0.2527210541167315,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}